Dexco Statistics

Total Valuation

Dexco has a market cap or net worth of BRL 4.79 billion. The enterprise value is 10.66 billion.

Market Cap	4.79B
Enterprise Value	10.66B

Important Dates

The next estimated earnings date is Tuesday, February 11, 2025.

Earnings Date	Feb 11, 2025
Ex-Dividend Date	Dec 19, 2024

Share Statistics

Dexco has 808.36 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	808.36M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	20.71%
Owned by Institutions (%)	20.08%
Float	306.18M

Valuation Ratios

The trailing PE ratio is 14.23 and the forward PE ratio is 11.35.

PE Ratio	14.23
Forward PE	11.35
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	0.83
P/FCF Ratio	48.37
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.71, with an EV/FCF ratio of 107.56.

EV / Earnings	31.65
EV / Sales	1.31
EV / EBITDA	4.71
EV / EBIT	10.71
EV / FCF	107.56

Financial Position

The company has a current ratio of 1.49, with a Debt / Equity ratio of 1.17.

Current Ratio	1.49
Quick Ratio	1.10
Debt / Equity	1.17
Debt / EBITDA	3.65
Debt / FCF	79.70
Interest Coverage	0.89

Financial Efficiency

Return on equity (ROE) is 5.25% and return on invested capital (ROIC) is 4.00%.

Return on Equity (ROE)	5.25%
Return on Assets (ROA)	3.20%
Return on Capital (ROIC)	4.00%
Revenue Per Employee	570,647
Profits Per Employee	23,673
Employee Count	14,228
Asset Turnover	0.46
Inventory Turnover	3.92

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.91% in the last 52 weeks. The beta is 0.88, so Dexco's price volatility has been lower than the market average.

Beta (5Y)	0.88
52-Week Price Change	-20.91%
50-Day Moving Average	6.79
200-Day Moving Average	7.33
Relative Strength Index (RSI)	36.59
Average Volume (20 Days)	3,899,761

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Dexco had revenue of BRL 8.12 billion and earned 336.82 million in profits.

Revenue	8.12B
Gross Profit	2.41B
Operating Income	898.27M
Pretax Income	406.93M
Net Income	336.82M
EBITDA	2.06B
EBIT	898.27M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 2.15 billion in cash and 7.90 billion in debt, giving a net cash position of -5.75 billion or -7.11 per share.

Cash & Cash Equivalents	2.15B
Total Debt	7.90B
Net Cash	-5.75B
Net Cash Per Share	-7.11
Equity (Book Value)	6.73B
Book Value Per Share	n/a
Working Capital	1.80B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.48 billion and capital expenditures -1.38 billion, giving a free cash flow of 99.11 million.

Operating Cash Flow	1.48B
Capital Expenditures	-1.38B
Free Cash Flow	99.11M
FCF Per Share	0.12

Full Cash Flow Statement

Margins

Gross margin is 29.63%, with operating and profit margins of 11.06% and 4.15%.

Gross Margin	29.63%
Operating Margin	11.06%
Pretax Margin	5.01%
Profit Margin	4.15%
EBITDA Margin	25.43%
EBIT Margin	11.06%
FCF Margin	1.22%

Dividends & Yields

This stock pays an annual dividend of 0.22, which amounts to a dividend yield of 3.65%.

Dividend Per Share	0.22
Dividend Yield	3.65%
Dividend Growth (YoY)	-84.55%
Years of Dividend Growth	n/a
Payout Ratio	0.02%
Buyback Yield	n/a
Shareholder Yield	3.65%
Earnings Yield	n/a
FCF Yield	2.07%

Dividend Details

Stock Splits

The last stock split was on December 21, 2022. It was a forward split with a ratio of 1.1.

Last Split Date	Dec 21, 2022
Split Type	Forward
Split Ratio	1.1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a